Aging and medications: Past, present, future

Clinical Pharmacology and Therapeutics

Volumn 85, Issue 1, 2009, Pages 3-10

  Schwartz, J B ^a,b   Abernethy, D R ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNITED STATES PHARMACOPEIA   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ADRENERGIC RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; CHOLINERGIC RECEPTOR; CYCLOOXYGENASE 2 INHIBITOR; CYTOCHROME P450; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE RECEPTOR; ENDORPHIN; ENKEPHALIN; GABAERGIC RECEPTOR AFFECTING AGENT; NEUROLEPTIC AGENT; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; NUTRACEUTICAL; POTASSIUM SPARING DIURETIC AGENT; RENIN INHIBITOR; SEROTONIN RECEPTOR; VERAPAMIL;

AGED; AGING; ANTICHOLINERGIC EFFECT; ANTICOAGULANT THERAPY; ARTHRITIS; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLEEDING; BRADYCARDIA; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM FUNCTION; COGNITIVE DEFECT; CORONARY ARTERY THROMBOSIS; DELIRIUM; DIABETES MELLITUS; DISORIENTATION; DRUG CLEARANCE; EDITORIAL; HEART FAILURE; HUMAN; HYPERTENSION; HYPOGLYCEMIA; KIDNEY CLEARANCE; ORTHOSTATIC HYPOTENSION; PARASYMPATHETIC TONE; PHARMACODYNAMICS; POLYPHARMACY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; QUALITY OF LIFE; SIDE EFFECT; URINE INCONTINENCE;

EID: 57749177407     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2008.238     Document Type: Editorial

References (19)

1. Laroche, M.L., Charmes, J.P., Bouthier, F. & Merle, L. (2008). Inappropriate medications in the elderly. Clin. Pharmacol. Ther 85, 94-97.
2. Hilmer, S.N. & Gnjidic, D. The effects of polypharmacy in older adults. Clin. Pharmacol. Ther 85, 86-88
3. Clark, C & Karlawish, J. Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies. Ann. Intern. Med. 138, 400-410 (2003).
4. Pollack, B.G., Forsyth, C.E. & Bies, R.R. The critical role of clinical pharmacology in geriatric psychopharmacology. Clin. Pharmacol. Ther 85, 89-93.
5. DuBeau, C.E. Therapeutic/pharmacologic approaches to urinary incontinence in older adults. Clin. Pharmacol. Ther 85, 98-102.
6. Holmes, H.M. Rational prescribing for patients with a reduced life expectancy. Clin. Pharmacol. Ther 85, 103-107.
7. Cockcroft, D.W. & Gault, M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16, 31-41 (1976).
8. Stevens, L.A. et al. Evaluation of the modification of diet in renal disease study equation in a large diverse population. J. Am. Soc. Nephrol. 18, 2749-2757 (2007).
9. Alexander, K.P. et al. Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors. Results from the CRUSADE. Circulation 114, 1380-1387 (2006).
10. Cotreau, M.M., von Moltke, L.L. & Greenblatt, D.J. The influence of age and sex on the clearance of cytochrome P450 3A substrates. Clin. Pharmacokinet. 44, 33-60 (2005).
11. Kang, D., Verotta, D. & Schwartz, J.B. Population analyses of amlodipine in patients living in the community and patients living in nursing homes. Clin. Pharmacol. Ther. 79, 114-124 (2006).
12. Schwartz, J.B. Erythromycin breath test results in elderly, very elderly, and frail elderly persons. Clin. Pharmacol. Ther. 79, 440-448 (2006).
13. Perlin, J.B., Kolodner, K.R. & Roswell, R.H. The Veterans Health Administration: quality, value, accountability, and information as transforming strategies for patient-centered care. Am. J. Manag. Care 10, 828-836 (2004).
14. Kuperman, G. & Bigson, R. Computer physician order entry: benefits, costs, and issues. Ann. Intern. Med. 139, 31-39 (2003).
15. Gronich, N. & Abernethy, D.R. Pharmacology across the aging continuum. In Pharmacology and Therapuetics (Waldman, S. & Terzic, A.) chap. 19 (Saunders, Philadelphia, in press).
16. Lakatta, E.G. & Sollott, S.J. Perspectives on mammalian cardiovascular aging: humans to molecules. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 132, 699-721 (2002).
17. Abernethy, D.R. & Schwartz, J.B. Calcium antagonist drugs. N. Engl. J. Med. 341, 1447-1457 (1999).
18. Funk, C.D. & Fitzgerald, G.A. COX-2 inhibitors and cardiovascular risk. J. Cardiovasc. Pharmacol. 50, 470-479 (2007).
19. US Food and Drug Administration. Guidelines for the Study of Drugs Likely to Be Used in the Elderly. Report HFD-100 (Department of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD, 1989).